The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, CA / ACCESS Newswire / December 10, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the ...
SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity ...
SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed ...
-Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024 -Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for ...
- Modular Medical (MODD) intends to deploy the MODD1 on a larger number of clinicians in mid August SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular Medical, Inc. ("Modular Medical" or the ...
SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
SAN DIEGO - Modular Medical, Inc. (NASDAQ:MODD), currently trading at $0.46 with a 25.24% year-to-date return, has started production of validation lots for disposable cartridges and infusion sets for ...
Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production. First Removable Tubeless Patch Pump: Pivot targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results